A r t i c l e s Targeting endogenous loci in live cells with nucleases designed to generate DNA double-stranded breaks (DSBs) at specific endogenous sequences without the need for substrate integration has been very useful for introducing targeted mutations and holds great promise for targeted gene therapy in humans [1] [2] [3] [4] . In this regard, the recently developed TALENs (transcription activator-like effector nucleases) and Cas9:sgRNA endonucleases (clustered, regularly interspaced, short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9): single guide RNA (sgRNA)) are particularly promising 5-10 . One continuing concern for employing TALENs and Cas9:sgRNAs for genome engineering, and for therapeutic human genome engineering in particular, is the potential for off-target DSB activity at nonconsensus sites within the genome for any given enzyme 2 . Current assays for such off-target nuclease activity involve cytotoxicity 11 , prediction-based modeling [12] [13] [14] select screening 12, 15, 16 and viral vector DSB traps 17, 18 . Such assays have been valuable for testing approaches designed to minimize undesired DNA cleavage activities of these enzymes 1,2 .
Targeting endogenous loci in live cells with nucleases designed to generate DNA double-stranded breaks (DSBs) at specific endogenous sequences without the need for substrate integration has been very useful for introducing targeted mutations and holds great promise for targeted gene therapy in humans [1] [2] [3] [4] . In this regard, the recently developed TALENs (transcription activator-like effector nucleases) and Cas9:sgRNA endonucleases (clustered, regularly interspaced, short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9): single guide RNA (sgRNA)) are particularly promising [5] [6] [7] [8] [9] [10] . One continuing concern for employing TALENs and Cas9:sgRNAs for genome engineering, and for therapeutic human genome engineering in particular, is the potential for off-target DSB activity at nonconsensus sites within the genome for any given enzyme 2 . Current assays for such off-target nuclease activity involve cytotoxicity 11 , prediction-based modeling [12] [13] [14] , select screening 12, 15, 16 and viral vector DSB traps 17, 18 . Such assays have been valuable for testing approaches designed to minimize undesired DNA cleavage activities of these enzymes 1, 2 .
TALENs are dimeric, site-specific nucleases with monomers consisting of an engineered DNA binding domain fused to a C-terminal FokI nuclease domain 9, 10 . Specific TALEN activity requires the dimerization of the FokI domain from two TALEN subunits with each monomer providing half of the specific DNA recognition sequence 2 . The DNA-binding code for TALENs allows targeting of DSBs with 5′ overhangs at nearly any position across different genomes 2, 19, 20 . For Cas9:sgRNA endonucleases, the Cas9 nuclease forms a complex with an engineered sgRNA comprising a chimeric CRISPR RNA and trans-activating CRISPR RNA 1 . Cas9:sgRNA sequence-specificity relies on hybridization of a 20-nt targeting sequence on the 5′ end of the sgRNA to complementary DNA and recognition of an 'NGG' protospacer-adjacent motif (PAM) on the noncomplementary strand. Cas9:sgRNA complexes, which, again, can be designed to cleave a multitude of sites across the genome, generate blunt DSB ends 3 bp into the 20-nt target sequence proximal to the PAM 1 .
Chromosomal translocations can arise by fusion of the ends of two DNA DSBs lying on heterologous chromosomes or on separated regions of a homologous chromosome 21, 22 . The HTGTS 23 and translocation-capture sequencing approaches 24 were developed to identify translocations of yeast I-SceI meganuclease-generated 'bait' DSBs at target sites introduced into the genome of mouse cells to other 'prey' cellular DSBs genome-wide. Correspondingly, these methods also identified various classes of endogenous DSBs in primary and transformed B-lymphocyte lineage cells [23] [24] [25] [26] [27] . HTGTS, which provides nucleotide-level resolution of junctions, further revealed I-SceI-generated DSBs at cryptic off-target sequences within the mouse genome 23 . Based on ability to detect off-target, I-SceI meganuclease sites across the mouse genome, we proposed HTGTS might be developed into a robust general method for determining off-target activity of engineered nucleases 23 . We now describe the development of an enhanced HTGTS approach and its application in human cells for identifying nuclease-generated, on-target and off-target DSBs and associated collateral chromosomal damage.
RESULTS
HTGTS assay for Cas9-generated DSBs at the human RAG1 locus To evaluate use of HTGTS for identifying on-and off-target custom nuclease activity in human cells, we first performed HTGTS using Cas9:sgRNA-generated DSBs as 'bait' to capture 'prey' sequences genome-wide in 293T cells culture for 48 h after transfection with Cas9:sgRNA. For these studies, we have now developed a modified HTGTS approach based on linear-amplification-mediated PCR (LAM-PCR) 28 that is more robust, cost-efficient and rapid than our prior emulsion-PCR 23 HTGTS (Fig. 1a, Supplementary Fig. 1 and Although great progress has been made in the characterization of the off-target effects of engineered nucleases, sensitive and unbiased genome-wide methods for the detection of off-target cleavage events and potential collateral damage are still lacking. Here we describe a linear amplification-mediated modification of a previously published high-throughput, genome-wide, translocation sequencing (HTGTS) method that robustly detects DNA double-stranded breaks (DSBs) generated by engineered nucleases across the human genome based on their translocation to other endogenous or ectopic DSBs. HTGTS with different Cas9:sgRNA or TALEN nucleases revealed off-target hotspot numbers for given nucleases that ranged from a few or none to dozens or more, and extended the number of known off-targets for certain previously characterized nucleases more than tenfold. We also identified translocations between bona fide nuclease targets on homologous chromosomes, an undesired collateral effect that has not been described previously. Finally, HTGTS confirmed that the Cas9D10A paired nickase approach suppresses off-target cleavage genome-wide.
A r t i c l e s Supplementary Table 1) . For initial studies, we selected the human RAG1 gene, a proposed target for gene correction therapy 29, 30 . To induce RAG1 DSBs, we generated four sgRNAs that each targeted a distinct sequence within a 317-bp region spanning the beginning of RAG1 exon 2; we refer to these four Cas9:sgRNA combinations as RAG1A, B, C and D (Fig. 1b and Supplementary Fig. 2a ). We performed HTGTS from the 3′ DSB end (with respect to RAG1 transcriptional orientation) of a given Cas9:RAG1-generated DSB, cloning from the A or B site by a specific primer positioned, respectively, 152 bp and 194 bp centromeric to the sites or from the C or D sites with a second specific primer positioned, respectively, 106 bp and 227 bp centromeric to them (Fig. 1b and Supplementary Fig. 2a) . For each HTGTS library, recovered junctions fused uniquely mapped coordinates corresponding to bait sequence and genome-wide prey sequences ( Supplementary Figs. 2b -e and 3a-c) and were mainly direct ('blunt') or had short microhomologies ( Supplementary  Fig. 3d-g ). On the bait-site side, junctions were enriched at or near the 3′ DSB bait-site end with enrichment decreasing along the bait sequence length, consistent with variable end resection before joining ( Supplementary Fig. 3a-c; see below) .
For each set of HTGTS libraries from a particular break-site or under particular conditions, we used modified Circos plots of the human genome organized into individual chromosomes to visualize overall junction patterns and key features 31 . In these plots, translocation hotspots, bioinformatically identified in an unbiased fashion as focally enriched HTGTS junction clusters, are indicated by lines that connect the bait-site to a given hotspot and range in color from dark red (highest junction enrichment) to yellow (lowest junction enrichment) ( Fig. 1c and Supplementary Fig. 2b-e) . We also denote HTGTS junction frequency within 5-Mb bins across all chromosomes on the Circos plots by black bars plotted on a log scale with custom axes (Fig. 1 legend) . For each bait site analyzed in this study, at least three (and usually many more) separate HTGTS libraries were generated with individual libraries ranging in size from several thousand to 80,000 independent junctions (Supplementary Table 1 and detailed for each experimental figure). Independent HTGTS libraries for a given site or condition gave reproducible overall results and conclusions ( Supplementary Fig. 2b -e and Supplementary Table 1; see below). Nonspecific HTGTS background was estimated as described 23 and found to be low (Supplementary Table 2 ).
Genome-wide off-target activities of Cas9:RAG1 sgRNAs By convention, prey sequences are joined to bait DSBs as in '+' (plus) orientation if they read from the junction in the p telomere to q telomere direction; correspondingly, junctions are in '−' (minus) orientation if in the other direction (Supplementary Fig. 4a ). Other than break-site junctions (see below), genome-wide Cas9:RAG1A-D HTGTS junctions occurred across the genome at similar frequencies in both orientations (Supplementary Fig. 1 npg heterogeneity in three-dimensional (3-D) genome organization 27, 33, 34 .
In this regard, we detected 33 highly significant, focally enriched prey junction hotspots from RAG1A and two from RAG1B libraries ( Fig. 1c, Supplementary Fig. 2b ,c and Supplementary Table 3 ).
In contrast, no hotspots were detected for RAG1C and RAG1D libraries, which based on random library size normalizations would have been readily detectable if they occurred at the level of RAG1A or RAG1B off-target sites ( Supplementary Fig. 2d ,e and legend). The RAG1A or RAG1B hotspot junctions showed expected characteristics for involvement of off-target DSBs, peaking precisely at predicted offtarget break-sites based on their being highly related (with 2-to 7-nt mismatches) to the respective bona fide on-target sequences of these two enzymes (Supplementary Table 3 and Supplementary Fig. 4b ). All junctions were fully consistent with DSB joining, displaying approximately equal numbers of (+) and (−) orientation joins that peaked at direct prey joins (no loss of nucleotides from predicted offtarget break-site) and tailed off in both orientations into joins with up to 100 bp of resection ( Supplementary Fig. 4c -e). Additional RAG1A studies at 24 h and 96 h after RAG1A transfection resulted in similar distributions of junctions genome-wide including RAG1A off-target sites ( Supplementary Fig. 5 ). Also, RAG1B HTGTS libraries in a different human cell line (A549 lung carcinoma cells) revealed the same two off-target hotspots ( Supplementary Fig. 6 ).
To unequivocally confirm that identified HTGTS off-target sites represented DSBs and further test the ability of HTGTS to identify offtarget nuclease-generated DSBs genome-wide, we performed HTGTS using, respectively, RAG1A high-level, off-target sites on chromosomes 12 or 19 or a RAG1A lower level, off-target site on chromosome 7 as bait ( Fig. 1d-f) . Strikingly, each bait produced HTGTS libraries with all characteristics expected for cloning from that specific off-target RAG1A bait DSB ( Fig. 1d-f; see below) . Moreover, all reproducibly captured the RAG1A on-target break-site as well as the vast majority of the off-target sites revealed by HTGTS from the on-target break-site (Fig. 1d-g ). Indeed, the most highly enriched off-target translocation sites recovered from the bona fide RAG1A on-target HTGTS bait were similarly highly enriched when each of the three RAG1A off-target sites were used as HTGTS bait ( Fig. 1g and Supplementary Table 3 ). The ability of these different HTGTS bait DSBs on different chromosomes to robustly identify essentially the same set of recurrent DSBs genome-wide is consistent with our prior findings on the influences of cellular heterogeneity in three-dimensional (3D) genome organization on the translocation landscape 27 . Likewise, the major difference in frequency of translocations captured by these four different RAG1A HTGTS baits was the enriched recovery of prey DSB junctions that fell onto the same chromosome as the particular bait-site (Supplementary Table 3 ), as also predicted by our prior studies 27, 33, 34 . Below, we present additional examples of such phenomena in the context of exploiting them to further facilitate HTGTS assays for nuclease off-target activity.
A common class of translocations for engineered nucleases HTGTS junctions are highly enriched in regions immediately around the break-site owing to DSB rejoining following resection, as well as various types of break-site proximal translocations (deletions, inversions and excision circles) 23 that are enhanced because of spatial proximity 27, 33 (Fig. 2a and Supplementary Fig. 7a ). Engineered endonucleases usually have target sites on both homologous chromosomes in diploid cells, and primer sequences for detecting junctions from bait DSBs are usually present on both alleles ( Supplementary  Fig. 7b ). Thus, most contributions from each of the homologous chromosome bait 3′ DSBs to break-site or genome-wide junctions cannot be distinguished. However, for the Cas9:RAG1A-D and RAG1A offtarget bait break-sites (and others, see below), we find a high density of prey junctions at or very close to the break-site in the (+) orientation quadrant, of which many would correspond to inversional translocations that in cells would generate dicentric chromosomes (Fig. 2b,c and Supplementary Fig. 7c-e) . In this regard, nucleotide sequences of such junctions confirm head-to-head inversional joins of the two break-sites, including perfect direct joins of the two Cas9 3′ DSB ends (Fig. 2d) , with additional junctions in this inversion/dicentric quadrant extending several 100 bp or more upstream likely due to 'prey' sequence resection. 
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A r t i c l e s
Cas9 paired nickase method suppresses off-target activity One approach to reduce Cas9:sgRNA offtarget activity is to use Cas9 D10A mutation (Cas9n), which renders the endonuclease into a nickase that generates DSBs from offset paired Cas9n:sgRNA combinations with variable length 5′ overhangs 35, 36 . To test this approach by HTGTS, we paired the off-target-prone RAG1A sgRNA with nearby downstream sgRNA targets (RAG1G, E and F), which would result in 5′ overhang DSBs of 28 nt, 36 nt and 51 nt, respectively, when used with Cas9n ( Fig. 3a and Supplementary Fig. 8a ). Cas9n:RAG1A/G, A/E or A/F HTGTS libraries had similar genome-wide characteristics to standard Cas9:RAG1A HTGTS libraries except that they lacked hotspots ( Fig. 3b-d) ; occasional junctions at RAG1A off-target sites were found upon inspection (Supplementary Table 3 ). Prey junctions around the break-site also revealed expected resection and translocation patterns ( Fig. 3e and Supplementary Fig. 8b,c) , including recurrent 'dicentric' (+) orientation junctions between break-sites on the two homologous chromosomes that encompassed the two offset nick sites (Fig. 3e,f and Supplementary Fig. 8b,c) .
TALEN-generated bait DSB HTGTS libraries
To test ability of HTGTS to reveal TALEN off-target DSBs, we employed two previously described TALENs 37 that, respectively, cleave the C-MYC gene on chromosome 8 or ATM gene on chromosome 11 ( Supplementary Fig. 9a,b) . The ATM and C-MYC TALEN bait HTGTS libraries showed similar patterns of break-site proximal junctions as those generated with Cas9:sgRNAs, including readily detectable dicentric orientation joins between the TALEN break-sites on homologous chromosomes (Supplementary Fig. 9c-e) . In addition, we detected a large number of off-target sites for both the ATM (522 off-target sites) and C-MYC (384 off-target sites) TALENs, of which all were lower frequency than the most robust Cas9:RAG1A off-targets ( Supplementary  Fig. 9a,b) . Notably, many highly enriched TALEN off-targets were pseudo-palindromic sequences that corresponded to variants of the recognition site of a single TALEN monomer (Supplementary Tables 4  and 5 and Supplementary Fig. 9f,g ; see Discussion). Both ATM and C-MYC TALEN bait libraries also reproducibly displayed a high enrichment of prey junctions along their respective break-site chromosomes ( Supplementary Fig. 9a,b ; see below).
Universal donor bait HTGTS assay for off-target detection
As illustrated by HTGTS from RAG1A off-target sites (Fig. 1) , a fixed bait DSB from one nuclease should detect both on-and off-target DSBs of a second nuclease. To test the ability of this "universal donor bait" HTGTS approach to detect different types of potential nucleasegenerated DSBs, we co-expressed RAG1B with I-SceI in 293T cells and used the RAG1B bait-site to capture I-SceI off-target sites (Fig. 4a-c) . Indeed, beyond the two expected RAG1B off-target sites, we reproducibly identified nine I-SceI off-target sites with 2-to 4-nt mismatches from the consensus (Fig. 4a,b, Supplementary Fig. 10a and Supplementary Table 6 ). I-SceI off-target sites displayed expected characteristics of such prey DSBs (Supplementary Fig. 10b,c) and were confirmed by in vitro I-SceI digestion (Supplementary Fig. 10d ). 
A r t i c l e s
We used the RAG1B universal donor bait HTGTS assay to evaluate previously described Cas9 EMX1 and VEGFA sgRNAs 15 . For both EMX1 and VEGFA sgRNA targets, RAG1B bait HTGTS identified, respectively, the single and the four off-target sites previously documented by the established T7 endonuclease I (T7EI) cleavage assay 15 , and also identified, respectively, an additional 12 and 34 novel offtarget sites (Fig. 4d-f) . Notably, all HTGTS-detected Cas9 EMX1 or VEGFA off-target sequences that we identified were related to the corresponding on-target sites and the majority were previously predicted but not confirmed (Supplementary Table 7 and Supplementary  Fig. 11a ) 12, 15, 16, 38 . When tested by the T7EI assay, we also detected the two on-target break-sites and three previously described off-target sites; but only one of four tested off-target sites revealed by HTGTS (Supplementary Fig. 11b ). Consistent with these findings, a prior T7EI assay study failed to detect 23 previously predicted Cas9 EMX1 or VEGFA sgRNA off-target sites 15 that were clearly identified by our unbiased HTGTS assay. The RAG1B co-expression HTGTS assays also identified a large number of ATM and C-MYC TALEN off-target sites including all of the ~100 most dominant off-target sites detected by HTGTS using the individual TALEN break-sites as bait (Fig. 4g-i,  Supplementary Fig. 9a,b and Supplementary Tables 4 and 5) .
Low-level DSBs that occur widely across the genome can greatly influence translocation profiles of a given bait DSB. Specifically, treating cells with ionizing radiation to generate random ectopic DSBs 'normalizes' DSB frequency genome-wide 27 , leading to diminution of dominant endogenous DSB hotspots and causing the length of a given break-site chromosome in cis to be a translocation hotspot region owing to a larger contribution of proximity effects 27, 33 .
To test ability of the RAG1B HTGTS assay to detect increased levels of widespread DSBs that do not qualify as hotspots individually (widespread low-level DSBs), we introduced RAG1B into 293T cells for 24 h, then treated them with 7Gy of ionizing radiation (to introduce ~140 random DSBs per cell 39 ), further cultured for 24 h and performed HTGTS from the RAG1B bait-site. As predicted from prior mouse cell studies 27 , ionizing radiation-treatment enhanced generation of HTGTS junctions that were greatly enriched across the entire RAG1B bait-site chromosome 11, with little or no increase on other chromosomes and a diminished recovery of break-site and recurrent off-target junctions ( Fig. 4c; compare with  Fig. 4a) . Furthermore, similar ionizing radiation-treatment results were obtained with RAG1A break-site bait HTGTS libraries for the on-target site on chromosome 11 and also with two tested RAG1A off-target sites on chromosomes 12 and 19 ( Supplementary Fig. 12) . Thus, subsequent to induction of widespread ionizing radiationgenerated DSBs genome-wide, each chromosome containing a particular on-target or off-target DSB hotspot became a hotspot region for the targeted DSBs they harbor. Cas9 EMX1 and VEGFA sgRNAs did not contribute markedly to increased junctions on the baitcontaining chromosome when used at the assayed concentration ( Fig. 4d,e; see discussion) . However, the ATM and C-MYC TALENs each generated substantially increased HTGTS junctions along the RAG1B break-site chromosome, reminiscent of that observed in the ionizing radiation-treated RAG1B bait libraries (Fig. 4g,h and  Supplementary Fig. 13 ; see Discussion). 
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A r t i c l e s
Titration of engineered nuclease genome-wide activities Increasing levels of ATM TALEN over a tenfold range revealed additional lower-level, off-target sites and suggested an apparent increase in widespread, low-level DSBs (Supplementary Fig. 14) . Assaying a single nuclease over increasing levels is not optimal for titrating on-target versus the various types of potential off-target activities, as both bait and prey breaks are influenced. Therefore, we employed the RAG1B bait assay to determine whether HTGTS could help assess optimal ATM TALEN nuclease levels for on-target versus off-target DSB activities. Frequencies of recovered ATM TALEN on-target versus the top five ATM off-target hotspot sites from RAG1B bait remained constant over a 100-fold tested range of ATM TALEN (Fig. 5a-d and Supplementary Fig. 15 ). As both on-target and off-target sites occurred at similar relative levels even at the lowest ATM TALEN concentrations, where on-target activity is low, relative off-target activities roughly corresponded to on-target activity (Fig. 5d,e) . In contrast, the relative level of on-target and offtarget activity to widespread, low-level DSB activity decreased as ATM TALEN concentration increased over the 100-fold range tested, indicating that HTGTS can be used to optimize relative levels of on-target versus the widespread, low-level activity of the ATM TALEN (Fig. 5e) . Increasing the amount of Cas9:RAG1B over an approximately tenfold range did not reveal additional off-target sites or increase the potentially very low-level, widespread DSB activity (Supplementary Fig. 16 ).
DISCUSSION
Robust and accessible methods to test for off-target DSB-inducing activities of engineered nucleases are important as this class of enzymes continues to be groomed for human therapeutic purposes 2 . We demonstrate that LAM-PCR-based HTGTS employing Cas9: sgRNAs, Cas9-paired nickases or TALEN bait DSBs provides a robust assay for identifying endogenous cellular DSB targets of these enzymes genome-wide in human cells. Thus, LAM-PCR-based HTGTS readily revealed off-target sites for a variety of different engineered nucleases. With respect to sensitivity, the off-target sites that we reproducibly detected in these studies included numerous sites predicted for previously tested nucleases but that had failed to be documented by existing methods, as well as a large number of off-target sites that were not predicted, but which were highly specific for each individually tested nuclease. Beyond off-target activities, we also found that HTGTS revealed apparently widespread, but very low-level, DSB-inducing activities of some nucleases. Further studies will be needed to determine whether this type of activity is generated by a large number of very infrequently cleaved off-target sites (i.e., requiring some degree of sequence recognition), an even more random DSB-generating activity, or a combination of the two. Whatever the case, this latter application of the HTGTS assay also should be useful for testing nonspecific DSB activity of chemotherapeutic and other agents. LAM-PCR-based HTGTS is a versatile assay that goes beyond simply detecting nuclease off-target sites by also revealing collateral damage in the form of recurrent translocations between on-target DSBs and off-target DSBs, as well as translocations between different off-target DSBs. Although not an 'off-target' event, HTGTS also revealed that a major translocation hotspot for on-target Cas9: sgRNA, Cas9-paired nickases, and TALEN-induced DSBs is the corresponding on-target DSB on the homologous chromosome that would lead to dicentric chromosome formation. Although probably being controlled substantially by cellular checkpoint responses in normal cells 40, 41 , dicentrics have the potential to generate additional genomic instability through breakage-fusion-bridge cycles 25 . Many such dicentric junctions likely originate from translocations between break-sites on the two homologs 23 that could be eliminated by engineered nucleases that recognize sequence nucleotide polymorphisms; but some conceivably could also result from stalled replication-forkmediated template switching 42 . Finally, our HTGTS findings indicate that widespread, low-level nuclease-generated DSBs can make each chromosome in a cell a marked hotspot region for translocations of on-target and/or off-target sites within it. Overall, HTGTS not only reveals all of these complex patterns of collateral damaged generated in the context of certain nucleases, but also provides an approach to estimate their relative frequency. npg Consistent with cellular heterogeneity in 3D genome organization allowing dominant DSB sites across the genome to drive recurrent translocations to each other 27, 33 , we identified the same large set of Cas9:RAG1A off-target DSBs in HTGTS assays that employed as bait, respectively, either the RAG1A on-target DSB site or three different RAG1A off-target DSB sites (each on a different chromosome). Based on this finding, we further improved the HTGTS assay by using the RAG1B DSB as a universal donor bait to identify on-target, off-target and low-level, widespread DSB activities of co-expressed nucleases. Indeed, this approach identified the known EMX1 and VEGFA sgRNA on-target and off-target sites, as well as many additional off-target sites. Thus, this modification of the HTGTS assay should facilitate rapid evaluation of on-target, off-target and lowlevel, widespread, DSB-generating activities of candidate nucleases from fixed-bait DSB sites without the need for generating and optimizing bait-site primers. Indeed, this approach can be used to identify engineered nuclease endogenous target sequences genome-wide even in cells that lack a known 'on-target' site for the nuclease tested as we showed for I-SceI.
The frequency of off-target sites for the four RAG1 Cas9:sgRNAs tested varied considerably, with two showing no detectable off-target activity. If desired, HTGTS could be scaled-up for even greater sensitivity and sensitivity also could be enhanced by performing HTGTS from target sites on each individual chromosome to increase identification of off-target sites on given chromosomes due to 3D proximity effects 27, 33 . HTGTS confirmed that off-target activity of the RAG1A sgRNA was dramatically suppressed genome-wide by the Cas9 D10 nickase approach 35, 36 ; but also revealed that this approach does not suppress translocations involving DSBs on both bait-site chromosomes. Although two tested TALENs had numerous off-target sites, a large fraction appeared to be generated by TALEN homodimers; thus, emerging approaches to enforce TALEN heterodimerization 43 should greatly reduce TALEN off-target activity. Finally, we found that HTGTS also may be used to optimize specific versus widespread, low-level, DSB-inducing activities by 'titration' of engineered nuclease levels. Given the wide-ranging variations in engineered nuclease ontarget versus off-target activities, such titration could greatly facilitate specific custom nuclease design.
METHODS
Methods and any associated references are available in the online version of the paper.
